IRIS
MONFORTE, Anna Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.349
EU - Europa 7.558
AS - Asia 4.175
SA - Sud America 1.306
Continente sconosciuto - Info sul continente non disponibili 143
AF - Africa 110
OC - Oceania 2
Totale 24.643
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.198
RU - Federazione Russa 3.852
SG - Singapore 1.617
CN - Cina 1.125
BR - Brasile 1.122
IE - Irlanda 888
SE - Svezia 732
VN - Vietnam 678
UA - Ucraina 578
DE - Germania 398
HK - Hong Kong 380
IT - Italia 280
FR - Francia 222
GB - Regno Unito 204
FI - Finlandia 197
IN - India 85
CA - Canada 70
AR - Argentina 69
MX - Messico 51
TR - Turchia 39
AT - Austria 38
BD - Bangladesh 37
EC - Ecuador 36
PL - Polonia 33
IQ - Iraq 32
ZA - Sudafrica 31
CZ - Repubblica Ceca 27
JP - Giappone 24
MA - Marocco 22
NL - Olanda 22
BE - Belgio 21
CO - Colombia 20
UZ - Uzbekistan 19
ES - Italia 18
CI - Costa d'Avorio 15
PK - Pakistan 15
ID - Indonesia 13
SA - Arabia Saudita 13
VE - Venezuela 13
IR - Iran 12
PY - Paraguay 11
CL - Cile 10
BO - Bolivia 9
NP - Nepal 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
IL - Israele 8
EG - Egitto 7
KE - Kenya 7
KG - Kirghizistan 7
PE - Perù 7
RO - Romania 7
UY - Uruguay 7
GE - Georgia 6
JO - Giordania 6
MY - Malesia 6
JM - Giamaica 5
SN - Senegal 5
AO - Angola 4
AZ - Azerbaigian 4
CH - Svizzera 4
CR - Costa Rica 4
GR - Grecia 4
LB - Libano 4
LT - Lituania 4
LV - Lettonia 4
OM - Oman 4
PS - Palestinian Territory 4
PT - Portogallo 4
SV - El Salvador 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
DO - Repubblica Dominicana 3
EU - Europa 3
HN - Honduras 3
KR - Corea 3
KW - Kuwait 3
PA - Panama 3
TT - Trinidad e Tobago 3
AU - Australia 2
BG - Bulgaria 2
BY - Bielorussia 2
CY - Cipro 2
GA - Gabon 2
GT - Guatemala 2
HU - Ungheria 2
LU - Lussemburgo 2
NI - Nicaragua 2
NO - Norvegia 2
PH - Filippine 2
QA - Qatar 2
SR - Suriname 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
DK - Danimarca 1
Totale 24.491
Salva come PNG Salva come JPEG
Città #
Dallas 4.953
Moscow 1.147
Jacksonville 1.081
Dublin 888
Singapore 854
Chandler 745
Ashburn 610
Dong Ket 507
Nyköping 482
Beijing 400
Hong Kong 380
San Jose 279
Council Bluffs 261
Princeton 178
Los Angeles 174
Cambridge 170
Medford 167
The Dalles 164
Dearborn 149
Lauterbourg 145
Des Moines 134
Boardman 113
Ann Arbor 86
Buffalo 79
New York 73
São Paulo 70
Wilmington 60
Ho Chi Minh City 59
Tianjin 54
Lancaster 49
Guangzhou 46
Belo Horizonte 41
Hanoi 40
Nanjing 40
Jinan 39
Messina 39
Woodbridge 39
Milan 38
San Mateo 38
Munich 37
Brooklyn 35
Orem 35
Vienna 35
Columbus 33
Shenyang 32
Redondo Beach 29
Houston 28
Warsaw 27
Brno 26
Rio de Janeiro 26
Montreal 25
Brasília 23
Haikou 22
Santa Clara 22
Tokyo 22
Hebei 21
Stockholm 21
Brussels 19
Chennai 19
Chicago 19
Ningbo 19
Pune 18
Shanghai 18
Tashkent 18
Denver 17
Frankfurt am Main 17
London 17
Phoenix 17
San Francisco 17
Zhengzhou 17
Amsterdam 16
Campinas 16
Abidjan 15
Nuremberg 15
Shenzhen 15
Johannesburg 14
Norwalk 14
Porto Alegre 14
Baghdad 13
Helsinki 13
Mumbai 13
Ottawa 13
Quito 13
Turku 13
Atlanta 12
Augusta 12
Boston 12
Changsha 12
Guayaquil 12
Manchester 12
Poplar 12
Seattle 12
Taiyuan 12
Catania 11
Hangzhou 11
Ardabil 10
Asunción 10
Casablanca 10
Duque de Caxias 10
Fuzhou 10
Totale 15.979
Salva come PNG Salva come JPEG
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 4.616
1-[3,5-bis(trifluoromethyl)phenyl]-1H,3H-thiazolo[3,4- a]benzimidazole 306
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 295
1-Aryl-1H,3H-thiazolo[3,4-a]benzimidazole derivatives 286
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 284
1,3-Thiazolidin-4-ones: potent and selective anti-HIV-1 agents 276
1-fluoromethyl-1-methyl-1H,3H-thiazolo-[3,4-a]benzimidazole 270
1-Adamantanamine derivatives as potential anti-HIV agents 254
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 241
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors 205
3H-AZIRINO[1,2-D][1,4]BENZODIAZEPIN-4 (5H)-ONES - SYNTHESIS AND STEREOCHEMISTRY 193
3-[2-(1H-1,3-benzodiazol-2-yl)ethyl]1,3-oxazolidin-2-one 191
3H-Azirino[1,2-d][1,4]benzodiazepin-4(5H)-ones: synthesis and stereochemistry 187
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 187
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 185
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 182
Anti-HIV agents: design and discovery of new potent RT inhibitors 175
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 174
Antiretroviral strategy using multi-target agents 166
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 164
13C NMR study of tetrahydrothiazolo[3,2-d][1,4]benzodiazepin-3(2H)-ones. 164
Graphene Quantum Dots Based Systems As HIV Inhibitors 163
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 161
Modificazioni strutturali del gruppo dichetoacido (DKA) di potenti inibitori dell'Integrasi dell'HIV-1 159
Synthesis and anti-HIV activity of carboxylated and drug-conjugated multi-walled carbon nanotubes 157
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 156
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 155
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 155
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 155
Annelated 1,5-benzothiazepines 152
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 151
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 149
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 148
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 147
Design e Sintesi di composti a struttura 3-Indol-Gliossilamidica come potenziali inibitori dell'integrasi dell'HIV-1. 144
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 144
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 143
Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT-inhibitors. 141
Ciclofunzionalizzazione di 1,4- e 1,5-benzodiazepine: sintesi e stereochimica di nuovi sistemi eteropoliciclici ottenuti per reazione con acidi mercaptoacetici 140
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 140
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 140
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 139
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones 139
Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation 139
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 138
Derivati benzimidazolonici ed analoghi come potenti inibitori non-nucleosidici dell'RT dell'HIV-1 138
NOVEL N1-ARYL-2- ARYLTHIOACETAMIDOBENZIMIDAZOLES WERE EFFECTIVE AGAINST HERPES SIMPLEX VIRUS 1 (HSV-1) REPLICATION IN VITRO 138
COMPUTATIONAL APPROACHES IN DISCOVERING NOVEL ANTI-AIDS AGENTS 137
Structural optimization of N1-aryl-benzimidazoles for the discovery of new non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains 136
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin- 4-(thi)one derivatives 135
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 135
Progettazione, Sintesi e SAR di analoghi 1,3-diidro-benzimidazoloni come nuovi agenti anti-HIV 133
Searching for novel N1-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitors 133
Anti-HIV agents .4. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazoles 132
Synthesis and structural features of new cyclofunctionalized benzimidazoles 130
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 130
Design, synthesis and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents 129
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 128
Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. 127
Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2 ',3 ': 4,5]imidazo[1,2- c]thiazoles 127
A thiazepino[4,5-a]benzimidazole derivative hampers the RNA replication of Eurasian serotypes of foot-and-mouth disease virus 126
ANTI-HIV AGENTS .3. SYNTHESIS AND IN-VITRO ANTI-HIV ACTIVITY OF NOVEL 1H,3H-THIAZOLO[3,4-A]IMIDAZO[4,5-B]PYRIDINES 123
Simulated human digestion of N1-aryl-2-arylthioacetamidobenzimidazoles and their activity against Herpes-simplex virus 1 in vitro 123
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents 122
Synthesis and antitumour activity of 1H,3H-thiazolo[3,4- a]benzimidazole derivatives 120
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli 1-sostituiti 117
Anti-enterovirus activity and structure-activity relationship of a series of 2,6-dihalophenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles 117
Compounds with potential antitumor activity. Note VIII 1-Alkyl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines. 117
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4- a] benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors 115
Synthesis and anti-HIV activity of 1-(2,6-difluorophenyl)- 1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2- substituted benzimidazoles 115
C-13 NMR-study of tetrahydrothiazolo-[2,3-D][1,4]benzodiazepin-3(2H)-ones 114
Sintesi e valutazione biologica di (ti)azepinobenzimidazoli come potenziali agenti anti-FMDV 113
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 112
Sintesi e proprietà anticonvulsivanti di 3-(1,3,4-tiadiazol-2-il)tiazolidin-4-oni. 112
ANTI-HIV AGENTS .1. SYNTHESIS AND INVITRO ANTI-HIV EVALUATION OF NOVEL 1H,3H-THIAZOLO[3,4-A]BENZIMIDAZOLES 111
Computational Strategies for Discovering novel HIV-1 RT Inhibitors 111
NOVEL PYRROLO- AND THIAZOLO-IMIDAZOLES 110
HIV-1 integrase strand transfer inhibitors (INSTIs): design, synthesis and biological activity 109
Rational design, synthesis and SAR of 1,3-dihydro-benzimidazolone analogues as new anti-HIV agents 107
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 106
Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitor 105
Synthesis and anti-HIV activity of TBZ structurally-related 1,2-substituted benzimidazoles 104
MOLECULAR MODELING STUDIES AND SYNTHESIS FOR THE DISCOVERY OF HIV-1 IN-LEDGF/P75 INTERACTION INHIBITORS 104
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 103
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 102
Synthesis and in vitro antitumour activity evaluation of 1-aryl-1H,3H-thiazolo[4,3-b]-quinazolines 101
Compounds with potential antitumor activity. VI - 2-Alkyl-3-[2-(1,3,4-thiadiazolyl)]-4-thiazolidinones. 101
Ligand-based drug design and docking studies of HIV-1 non-nucleoside RT inhibitors 101
Anti-HIV agents: design and discovery of new potent RT inhibitors 100
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 99
Pharmacophore Modeling, Docking Experiments And Discovery Of New Hiv-1 NNRTIs 99
Synthesis and biological activity of novel non-nucleoside HIV-1 RT inhibitors 99
Molecular Modeling Studies: Discovery of Novel Potent Non-Nucleoside RT Inhibitors 97
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 96
ENANTIOMERIC RESOLUTION: HPLC ON CHIRAL STATIONARY PHASE OF ANTI-HIV AGENTS. 96
TBZ-analoghi inibitori non nucleosidici della HIV-RT 95
Sintesi ed attività anti-HIV di derivati 4-tiazolidinonici. 95
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent HIV-1 NNRTIs by molecular modeling studies 95
SYNTHESIS AND ANTIHYPERTENSIVE ACTIVITY EVALUATION OF INDOLE- DERIVATIVES N-ACETAMIDO SUBSTITUTED 95
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 95
Totale 18.826
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.269
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.043 0 229 26 32 78 8 69 40 28 10 155 368
2022/20232.881 237 216 122 228 255 300 80 180 1.124 12 93 34
2023/2024545 58 101 41 93 52 84 1 23 2 29 12 49
2024/20252.858 54 35 73 212 114 100 31 666 760 116 230 467
2025/202612.756 317 1.805 3.657 699 661 2.055 1.035 1.037 1.020 293 104 73
2026/2027370 130 240 0 0 0 0 0 0 0 0 0 0
Totale 24.643